A urine analyzer is a medical device that is used in the clinical setting to perform automatic urine testing. It is used to diagnose and monitor renal, and urinary tract abnormalities and quantify a number of analytes that includes protein, glucose, bilirubin, and red blood cells. It is commonly used in clinical laboratories, hospitals, and diagnostic centers among others. In addition, urine analyzer offers benefits such as benefits of convenience, efficiency, and increased sensitivity for detecting renal and urinary tract illnesses. Several models contain urine strip readers, a type of reflectance photometer that can process various hundred strips per hour.
Highlights from Urine Chemistry Analyzers Market Study
|Value (USD Million)
The key Players profiled in the report are F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (Beckman Coulter, Inc.) (United States), Abbott Laboratories (United States), Siemens AG (Germany), Horiba, Ltd. (Japan), Thermo Fisher Scientific Inc (United States), Sysmex Corporation (Japan), Hitachi (Japan), Zoetis Inc. (Abaxis) (United States), EKF Diagnostics (Germany), Ortho Clinical Diagnostics (United States) and ELITechGroup (France).
Geographic Breakdown and Segment Analysis
The Global Urine Chemistry Analyzers market presents a comprehensive analysis of the Urine Chemistry Analyzers market by product type (Benchtop and Portable), by end-user/application (Hospitals, Clinics, Home Healthcare, Diagnostic Centers and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Urine Chemistry Analyzers industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Urine Chemistry Analyzers market
Analyst at AMA have segmented the market study of Global Urine Chemistry Analyzers market by Type, Application and Region.
Influencing Trend:Growing Demand for Portable and Benchtop Clinical Chemistry Analyzers
Market Growth Drivers:Rising Adoption of Point of Care Diagnostic Tests and Increasing Geriatric Population Coupled with Rising Prevalence of Chronic Diseases
Challenges:Lack of professional and skilled workforce
Restraints:High Costs of Clinical Analyzers
Opportunities:Growing Implementation of Favourable Government Initiatives and Increasing Technology Improvements in Clinical Chemistry Analysers.
Market Developments Activities:In February 2021, HORIBA acquired MedTest Dx and Pointe Scientific to expand the company’s laboratory chemistry offerings. This acquisition aimed to continue to offer innovative technology and address the multidisciplinary requirements of IVD 1 testing customers, thus aiding in accelerating the company’s global market presence.
In January 2022, Thermo Fisher Scientific Inc announced the completion its acquisition of PeproTech on 30th December 2021 for a total cash purchase price of nearly USD 1.85 billion. PeproTech is among the leader in recombinant proteins, thus this acquisition will strengthen the company’s product portfolio and market presence.
Urine Chemistry Analyzers are a fragmented market due to the presence of various players. The players are focusing on enhancing healthcare expenditure and improving healthcare infrastructure. In addition, players are highly investing in research and development activities and incorporating cutting-edge technology to enhance their market presence. These players are also strategically involved in activities such as product development, partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.
Key Target AudienceUrine Chemistry Analyzers Manufacturers Suppliers and Distributors, Venture Capitalists and Private Equity Firms, New Entrants/Investors, Strategic Business Planners, Government Regulatory, Research Organizations and End-Use Industries